Overview
Dr. Reitman’s clinical interests include radiotherapy for primary and metastatic tumors of the brain and spine. He is also interested in basic and translational research studies to develop new treatment approaches for pediatric and adult brain tumors. He uses genomic analysis, radiation biology studies, and genetically engineered animal models of cancer to carry out this research
Current Appointments & Affiliations
Associate Professor of Radiation Oncology
·
2026 - Present
Radiation Oncology,
Clinical Science Departments
Assistant Professor of Pathology
·
2022 - Present
Pathology,
Clinical Science Departments
Assistant Professor in Neurosurgery
·
2022 - Present
Neurosurgery,
Neurosurgery
Member of the Duke Cancer Institute
·
2019 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Investigating the FLASH Effect in a Rat Brain Organotypic Model With a Novel High-Energy Electron Beam.
Journal Article Int J Radiat Oncol Biol Phys · March 1, 2026 PURPOSE: Ultrahigh dose rate (FLASH) radiation therapy is reported to reduce normal tissue toxicity while maintaining tumor control; however, mechanism(s) remain obscure. To study FLASH mechanisms in brain tissue, we developed a novel experimental platform ... Full text Link to item CiteComparison of Local Medicare Guidance and Medicare Advantage Plans for Stereotactic Radiosurgery for Brain Metastases.
Journal Article Adv Radiat Oncol · February 2026 PURPOSE: Medicare Advantage operates under a capitated payment model, where Medicare Advantage Organizations (MAOs) must provide services that meet or exceed Medicare Parts A and B standards, ensuring actuarial equivalence. MAOs are mandated to base their ... Full text Link to item CiteThe 2024 Brain Tumor Segmentation Challenge Meningioma Radiotherapy (BraTS-MEN-RT) dataset.
Journal Article Sci Data · January 27, 2026 Meningiomas are the most common primary intracranial tumors, frequently requiring radiotherapy as a part of management. Effective radiotherapy planning for meningiomas necessitates accurate and consistent segmentation of target volumes on MRI, a process th ... Full text Link to item CiteRecent Grants
Inflammasomes - a driver of sexual dimorphism to glioma therapies
ResearchCo Investigator · Awarded by National Institutes of Health · 2025 - 2030Role of ATRX deficiency as a determinant of topoisomerase 1 inhibitor sensitivity in high grade gliomas
ResearchCo Investigator · Awarded by American Cancer Society, Inc. · 2025 - 2028Modulation of STING to enhance the efficacy of treatments for diffuse midline glioma
ResearchPrincipal Investigator · Awarded by Alex's Lemonade Stand · 2024 - 2028View All Grants
Education
Duke University, School of Medicine ·
2014
M.D.
Duke University, School of Medicine ·
2012
Ph.D.